Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jun 30, 2010


Sirius Genomics this week announced that Kamran Alam has been appointed senior director of business development.

Alam brings to Sirius 12 of years experience in the biotech and medical device industry. Before joining Sirius Genomics, Alam held positions at the Center for Drug Research and Development, Angiotech Pharmaceuticals, and AnorMED, where his work focused on executing partnering deals, mergers, acquisitions, and licensing transactions.

"Sirius Genomics is on track with our existing products and looking to grow our pipeline," Chris Wagner, CEO of Sirius Genomics, said in a statement announcing Alam's appointment. Alam's "extensive background in partnering with both global pharmaceutical and medical device companies, as well as experience in building collaborations with academic and translational research centers, will support our commercialization initiatives and product pipeline development."

Stan Lapidus is the founder, president, and CEO of SynapDx, a new company developing diagnostic tests for the early detection of autism. He is a co-founder of Helicos BioSciences, Cytyc, and Exact Sciences.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.